OBJECTIVE: The objective of this study was to relate a novel test of identifying and recalling odor percepts to biomarkers of Alzheimer's disease (AD) in well-characterized elderly individuals, ranging from cognitively normal to demented. METHODS: One hundred eighty-three participants (cognitively normal: n = 70; subjective cognitive concerns: n = 74; mild cognitive impairment [MCI]: n = 29, AD dementia: n = 10) were administered novel olfactory tests: the Odor Percept IDentification (OPID) and the Percepts of Odor Episodic Memory (POEM) tests. Univariate cross-sectional analyses of performance across diagnoses; logistic regression modeling, including covariates of age, sex, education, APOE genotype, and neuropsychological test scores; and linear mixed modeling of longitudinal cognitive scores were performed. Amyloid deposition and MRI volumetrics were analyzed in a subset of participants. RESULTS: Accuracy of identification and episodic memory of odor percepts differed significantly across diagnosis and age, with progressively worse performance across degrees of impairment. Among the participants who were cognitively normal or had subjective cognitive concerns, poorer than expected performance on the POEM test (based on the same individual's performance on the OPID and odor discrimination tests) was associated with higher frequencies of the APOE ε4 allele, thinner entorhinal cortices, and worse longitudinal trajectory of Logical Memory scores. INTERPRETATION: Selective impairment of episodic memory of odor percepts, relative to identification and discrimination of odor percepts revealed by this novel POEM battery, is associated with biomarkers of AD in a well-characterized pre-MCI population. These affordable, noninvasive olfactory tests offer potential to identify clinically normal individuals who have greater likelihood of future cognitive decline. Ann Neurol 2016;80:846-857.
OBJECTIVE: The objective of this study was to relate a novel test of identifying and recalling odor percepts to biomarkers of Alzheimer's disease (AD) in well-characterized elderly individuals, ranging from cognitively normal to demented. METHODS: One hundred eighty-three participants (cognitively normal: n = 70; subjective cognitive concerns: n = 74; mild cognitive impairment [MCI]: n = 29, AD dementia: n = 10) were administered novel olfactory tests: the Odor Percept IDentification (OPID) and the Percepts of Odor Episodic Memory (POEM) tests. Univariate cross-sectional analyses of performance across diagnoses; logistic regression modeling, including covariates of age, sex, education, APOE genotype, and neuropsychological test scores; and linear mixed modeling of longitudinal cognitive scores were performed. Amyloid deposition and MRI volumetrics were analyzed in a subset of participants. RESULTS: Accuracy of identification and episodic memory of odor percepts differed significantly across diagnosis and age, with progressively worse performance across degrees of impairment. Among the participants who were cognitively normal or had subjective cognitive concerns, poorer than expected performance on the POEM test (based on the same individual's performance on the OPID and odor discrimination tests) was associated with higher frequencies of the APOE ε4 allele, thinner entorhinal cortices, and worse longitudinal trajectory of Logical Memory scores. INTERPRETATION: Selective impairment of episodic memory of odor percepts, relative to identification and discrimination of odor percepts revealed by this novel POEM battery, is associated with biomarkers of AD in a well-characterized pre-MCI population. These affordable, noninvasive olfactory tests offer potential to identify clinically normal individuals who have greater likelihood of future cognitive decline. Ann Neurol 2016;80:846-857.
Authors: Matthias H Tabert; Xinhua Liu; Richard L Doty; Michael Serby; Diana Zamora; Gregory H Pelton; Karen Marder; Mark W Albers; Yaakov Stern; D P Devanand Journal: Ann Neurol Date: 2005-07 Impact factor: 10.422
Authors: Monique A M Smeets; Hendrik N J Schifferstein; Sarai R Boelema; Gerty Lensvelt-Mulders Journal: Chem Senses Date: 2008-07-11 Impact factor: 3.160
Authors: Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson Journal: Neuron Date: 2009-07-30 Impact factor: 17.173
Authors: Maria C Carrillo; Andrew Blackwell; Harald Hampel; Johan Lindborg; Reisa Sperling; Dale Schenk; Jeffrey J Sevigny; Steven Ferris; David A Bennett; Suzanne Craft; Timothy Hsu; William Klunk Journal: Alzheimers Dement Date: 2009-03 Impact factor: 21.566
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Maryann P Platt; Kevin A Bolding; Charlotte R Wayne; Sarah Chaudhry; Tyler Cutforth; Kevin M Franks; Dritan Agalliu Journal: Proc Natl Acad Sci U S A Date: 2020-03-11 Impact factor: 11.205
Authors: William Charles Kreisl; Peng Jin; Seonjoo Lee; Ezra R Dayan; Shankar Vallabhajosula; Gregory Pelton; José A Luchsinger; Gnanavalli Pradhaban; D P Devanand Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Marie-Elyse Lafaille-Magnan; Judes Poirier; Pierre Etienne; Jennifer Tremblay-Mercier; Joanne Frenette; Pedro Rosa-Neto; John C S Breitner Journal: Neurology Date: 2017-06-28 Impact factor: 9.910
Authors: Sarah M Buchanan; Thomas D Parker; Christopher A Lane; Ashvini Keshavan; Sarah E Keuss; Kirsty Lu; Sarah-Naomi James; Heidi Murray-Smith; Andrew Wong; Jennifer Nicholas; David M Cash; Ian B Malone; William Coath; David L Thomas; Carole Sudre; Nick C Fox; Marcus Richards; Jonathan M Schott Journal: J Neurol Date: 2020-06-24 Impact factor: 4.849
Authors: Jaehong Suh; Donna M Romano; Larissa Nitschke; Scott P Herrick; Britt A DiMarzio; Volodymyr Dzhala; Jun-Seok Bae; Mary K Oram; Yuejiao Zheng; Basavaraj Hooli; Kristina Mullin; Vincenzo A Gennarino; Wilma Wasco; Jeremy D Schmahmann; Mark W Albers; Huda Y Zoghbi; Rudolph E Tanzi Journal: Cell Date: 2019-08-22 Impact factor: 41.582